Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
What’s After The Letters? Industry Awaits US FDA’s Next Steps In Ad/Promo Crackdown
Jan 06 2026
•
By
Sue Sutter
perspectives 2026
FDA will have do more than send letters to give its ad/promo enforcement push some teeth.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pink Sheet Perspectives
More from Marketing & Advertising